Buy Or Sell Opportunity • Jun 25
Now 23% undervalued Over the last 90 days, the stock has risen 12% to NT$39.25. The fair value is estimated to be NT$51.03, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.8% over the last 3 years. Earnings per share has grown by 28%. Buy Or Sell Opportunity • Jun 08
Now 24% undervalued Over the last 90 days, the stock has risen 62% to NT$39.95. The fair value is estimated to be NT$52.72, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 7.8% over the last 3 years. Earnings per share has grown by 28%. Reported Earnings • May 13
First quarter 2026 earnings released: EPS: NT$0.24 (vs NT$0.22 loss in 1Q 2025) First quarter 2026 results: EPS: NT$0.24 (up from NT$0.22 loss in 1Q 2025). Revenue: NT$360.8m (up 15% from 1Q 2025). Net income: NT$23.8m (up NT$45.7m from 1Q 2025). Profit margin: 6.6% (up from net loss in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has increased by 39% per year, which means it is tracking significantly ahead of earnings growth. Buy Or Sell Opportunity • May 11
Now 22% undervalued Over the last 90 days, the stock has risen 87% to NT$45.30. The fair value is estimated to be NT$58.04, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.5% over the last 3 years. Earnings per share has grown by 14%. Buy Or Sell Opportunity • Apr 24
Now 26% undervalued Over the last 90 days, the stock has risen 118% to NT$45.30. The fair value is estimated to be NT$61.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.5% over the last 3 years. Earnings per share has grown by 14%. New Risk • Apr 19
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 12% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 50% per year over the past 5 years. Reported Earnings • Mar 13
Full year 2025 earnings released: NT$0.80 loss per share (vs NT$0.21 loss in FY 2024) Full year 2025 results: NT$0.80 loss per share (further deteriorated from NT$0.21 loss in FY 2024). Revenue: NT$1.35b (up 4.2% from FY 2024). Net loss: NT$80.3m (loss widened 278% from FY 2024). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 26% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Mar 09
Epileds Technologies, Inc., Annual General Meeting, Jun 23, 2026 Epileds Technologies, Inc., Annual General Meeting, Jun 23, 2026. Location: no,12, nan k`o 2nd rd., sinshih district, tainan city Taiwan New Risk • Dec 17
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 44% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.3% average weekly change). Market cap is less than US$100m (NT$2.10b market cap, or US$66.8m). Board Change • Dec 13
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 6 non-independent directors. Independent Director Ling-Yi Chan was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Nov 12
Third quarter 2025 earnings released: NT$0.04 loss per share (vs NT$0.004 loss in 3Q 2024) Third quarter 2025 results: NT$0.04 loss per share (further deteriorated from NT$0.004 loss in 3Q 2024). Revenue: NT$367.9m (up 2.5% from 3Q 2024). Net loss: NT$4.11m (loss widened NT$3.68m from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 10% per year, which means it is well ahead of earnings. Reported Earnings • Aug 13
Second quarter 2025 earnings released: NT$0.77 loss per share (vs NT$0.021 profit in 2Q 2024) Second quarter 2025 results: NT$0.77 loss per share (down from NT$0.021 profit in 2Q 2024). Revenue: NT$347.2m (up 3.1% from 2Q 2024). Net loss: NT$77.3m (down NT$79.4m from profit in 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings. Reported Earnings • May 13
First quarter 2025 earnings released: NT$0.22 loss per share (vs NT$0.13 loss in 1Q 2024) First quarter 2025 results: NT$0.22 loss per share (further deteriorated from NT$0.13 loss in 1Q 2024). Revenue: NT$313.0m (up 16% from 1Q 2024). Net loss: NT$22.0m (loss widened 68% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has increased by 12% per year, which means it is well ahead of earnings. New Risk • May 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 9.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$161m free cash flow). Earnings have declined by 18% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (9.1% average weekly change). Market cap is less than US$100m (NT$2.75b market cap, or US$92.2m). Announcement • May 01
Epileds Technologies, Inc. to Report Q1, 2025 Results on May 08, 2025 Epileds Technologies, Inc. announced that they will report Q1, 2025 results on May 08, 2025 Reported Earnings • Mar 06
Full year 2024 earnings released: NT$0.21 loss per share (vs NT$1.38 loss in FY 2023) Full year 2024 results: NT$0.21 loss per share (improved from NT$1.38 loss in FY 2023). Revenue: NT$1.29b (up 14% from FY 2023). Net loss: NT$21.3m (loss narrowed 85% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 85 percentage points per year, which is a significant difference in performance. Announcement • Feb 24
Epileds Technologies, Inc., Annual General Meeting, Jun 20, 2025 Epileds Technologies, Inc., Annual General Meeting, Jun 20, 2025. Location: no,12, nan k`o 2nd rd., sinshih district, tainan city Taiwan Announcement • Feb 14
Epileds Technologies, Inc. to Report Fiscal Year 2024 Results on Feb 21, 2025 Epileds Technologies, Inc. announced that they will report fiscal year 2024 results on Feb 21, 2025 New Risk • Dec 19
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: NT$3.23b (US$98.8m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$119m free cash flow). Share price has been highly volatile over the past 3 months (9.7% average weekly change). Earnings have declined by 11% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NT$3.23b market cap, or US$98.8m). New Risk • Nov 18
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -NT$119m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-NT$119m free cash flow). Share price has been highly volatile over the past 3 months (10% average weekly change). Earnings have declined by 11% per year over the past 5 years. New Risk • Sep 12
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Taiwanese stocks, typically moving 9.3% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.3% average weekly change). Earnings have declined by 2.4% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NT$2.70b market cap, or US$83.9m). Reported Earnings • Aug 13
Second quarter 2024 earnings released: EPS: NT$0.02 (vs NT$0.23 loss in 2Q 2023) Second quarter 2024 results: EPS: NT$0.02 (up from NT$0.23 loss in 2Q 2023). Revenue: NT$336.9m (up 15% from 2Q 2023). Net income: NT$2.13m (up NT$24.9m from 2Q 2023). Profit margin: 0.6% (up from net loss in 2Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance. Announcement • Jul 31
Epileds Technologies, Inc. to Report Q2, 2024 Results on Aug 07, 2024 Epileds Technologies, Inc. announced that they will report Q2, 2024 results on Aug 07, 2024 New Risk • Jun 06
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (NT$2.30b market cap, or US$71.3m). Reported Earnings • May 19
First quarter 2024 earnings released: NT$0.13 loss per share (vs NT$0.25 loss in 1Q 2023) First quarter 2024 results: NT$0.13 loss per share (improved from NT$0.25 loss in 1Q 2023). Revenue: NT$270.0m (down 10.0% from 1Q 2023). Net loss: NT$13.1m (loss narrowed 49% from 1Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance. Announcement • May 02
Epileds Technologies, Inc. to Report Q1, 2024 Results on May 08, 2024 Epileds Technologies, Inc. announced that they will report Q1, 2024 results on May 08, 2024 Reported Earnings • Mar 20
Full year 2023 earnings released: NT$1.38 loss per share (vs NT$0.72 loss in FY 2022) Full year 2023 results: NT$1.38 loss per share (further deteriorated from NT$0.72 loss in FY 2022). Revenue: NT$1.13b (down 5.2% from FY 2022). Net loss: NT$138.8m (loss widened 92% from FY 2022). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. Announcement • Feb 24
Epileds Technologies, Inc., Annual General Meeting, Jun 20, 2024 Epileds Technologies, Inc., Annual General Meeting, Jun 20, 2024. Location: No.12, Nanke 2rd Rd., Xinshi Dist., Tainan City Taiwan Agenda: To report the business of 2023; to accept 2023 Business Report and Financial Statements; to approve the Proposal for the Company's 2023 Deficit Compensation; to raise funds through issuing new shares or GDRs; and to consider other matters. Announcement • Feb 06
Epileds Technologies, Inc. Announces Change in Representative of the Institutional Director Epileds Technologies, Inc. announced change in representative of the institutional director. Name of the previous position holder: Mr. Ming-Yu Huang. Resume of the previous position holder: Representative of Vision Holdings Ltd. Name of the new position holder: Mr. Qi-Xian Chen. Resume of the new position holder: Representative of Vision Holdings Ltd. Effective date of the new appointment is February 5, 2024. Reported Earnings • Aug 09
Second quarter 2023 earnings released: NT$0.23 loss per share (vs NT$0.074 loss in 2Q 2022) Second quarter 2023 results: NT$0.23 loss per share (further deteriorated from NT$0.074 loss in 2Q 2022). Revenue: NT$293.1m (down 2.3% from 2Q 2022). Net loss: NT$22.8m (loss widened 207% from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 26% per year but the company’s share price has only fallen by 8% per year, which means it has not declined as severely as earnings. Valuation Update With 7 Day Price Move • Feb 03
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to NT$16.35, the stock trades at a trailing P/E ratio of 64.3x. Average trailing P/E is 13x in the Semiconductor industry in Taiwan. Total returns to shareholders of 28% over the past three years. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Upcoming Dividend • Aug 17
Upcoming dividend of NT$0.40 per share Eligible shareholders must have bought the stock before 24 August 2022. Payment date: 20 September 2022. Trailing yield: 2.3%. Lower than top quartile of Taiwanese dividend payers (6.5%). Lower than average of industry peers (3.5%). Reported Earnings • Aug 15
Second quarter 2022 earnings released: NT$0.07 loss per share (vs NT$0.39 profit in 2Q 2021) Second quarter 2022 results: NT$0.07 loss per share (down from NT$0.39 profit in 2Q 2021). Revenue: NT$300.1m (down 35% from 2Q 2021). Net loss: NT$7.43m (down 119% from profit in 2Q 2021). Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 19
Investor sentiment improved over the past week After last week's 19% share price gain to NT$17.00, the stock trades at a trailing P/E ratio of 13.7x. Average trailing P/E is 12x in the Semiconductor industry in Taiwan. Total returns to shareholders of 12% over the past three years. Reported Earnings • May 11
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind First quarter 2022 results: EPS: NT$0.19 (down from NT$0.38 in 1Q 2021). Revenue: NT$330.3m (down 25% from 1Q 2021). Net income: NT$19.0m (down 51% from 1Q 2021). Profit margin: 5.7% (down from 8.7% in 1Q 2021). The decrease in margin was driven by lower revenue. Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 9.8%. Over the last 3 years on average, earnings per share has increased by 105% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Board Change • Apr 27
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Mar 13
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2021 results: EPS: NT$1.44 (up from NT$0.16 in FY 2020). Revenue: NT$1.76b (up 35% from FY 2020). Net income: NT$144.1m (up NT$127.9m from FY 2020). Profit margin: 8.2% (up from 1.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 4.3%. Earnings per share (EPS) missed analyst estimates by 9.8%. Over the last 3 years on average, earnings per share has increased by 96% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Announcement • Mar 06
Epileds Technologies, Inc., Annual General Meeting, Jun 16, 2022 Epileds Technologies, Inc., Annual General Meeting, Jun 16, 2022. Reported Earnings • Nov 11
Third quarter 2021 earnings released: EPS NT$0.37 (vs NT$0.039 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: NT$477.6m (up 34% from 3Q 2020). Net income: NT$36.9m (up NT$33.0m from 3Q 2020). Profit margin: 7.7% (up from 1.1% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 70% per year but the company’s share price has only increased by 18% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 11
Investor sentiment deteriorated over the past week After last week's 15% share price decline to NT$26.05, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 16x in the Semiconductor industry in Taiwan. Total returns to shareholders of 27% over the past three years. Reported Earnings • Aug 01
Second quarter 2021 earnings released: EPS NT$0.39 (vs NT$0.054 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: NT$459.3m (up 49% from 2Q 2020). Net income: NT$38.8m (up NT$33.4m from 2Q 2020). Profit margin: 8.5% (up from 1.8% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 6% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 23
Investor sentiment improved over the past week After last week's 16% share price gain to NT$31.15, the stock trades at a trailing P/E ratio of 40.3x. Average trailing P/E is 27x in the Semiconductor industry in Taiwan. Total returns to shareholders of 34% over the past three years. Valuation Update With 7 Day Price Move • Jul 07
Investor sentiment improved over the past week After last week's 17% share price gain to NT$26.40, the stock trades at a trailing P/E ratio of 34.1x. Average trailing P/E is 24x in the Semiconductor industry in Taiwan. Total returns to shareholders of 18% over the past three years. Valuation Update With 7 Day Price Move • May 14
Investor sentiment deteriorated over the past week After last week's 19% share price decline to NT$20.05, the stock trades at a trailing P/E ratio of 25.9x. Average forward P/E is 14x in the Semiconductor industry in Taiwan. Total loss to shareholders of 8.1% over the past three years. Reported Earnings • May 05
First quarter 2021 earnings released: EPS NT$0.38 (vs NT$0.23 loss in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: NT$438.0m (up 74% from 1Q 2020). Net income: NT$38.3m (up NT$61.5m from 1Q 2020). Profit margin: 8.7% (up from net loss in 1Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 12% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Announcement • Mar 12
Epileds Technologies, Inc., Annual General Meeting, Jun 17, 2021 Epileds Technologies, Inc., Annual General Meeting, Jun 17, 2021. Is New 90 Day High Low • Dec 31
New 90-day high: NT$21.90 The company is up 20% from its price of NT$18.20 on 30 September 2020. The Taiwanese market is up 17% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Semiconductor industry, which is up 24% over the same period. Is New 90 Day High Low • Dec 07
New 90-day high: NT$20.75 The company is up 10.0% from its price of NT$18.90 on 08 September 2020. The Taiwanese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 21% over the same period. Reported Earnings • Nov 08
Third quarter 2020 earnings released: EPS NT$0.04 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: NT$357.3m (up 26% from 3Q 2019). Net income: NT$3.91m (up NT$26.3m from 3Q 2019). Profit margin: 1.1% (up from net loss in 3Q 2019). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 80% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Sep 25
New 90-day low: NT$17.85 The company is down 11% from its price of NT$19.95 on 24 June 2020. The Taiwanese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Semiconductor industry, which is up 23% over the same period.